학술논문
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT
Document Type
Article
Author
Beksac, M.; Eikema, D.-J.; Koster, L.; Hulin, C.; Poiré, X.; Hamladji, R.-M.; Gromek, T.; Bazarbachi, A.; Ozkurt, Z.N.; Pabst, T.; Ben Othman, T.; Finke, J.; Pirogova, O.; Wu, D.; Hayat, A.; Hilgendorf, I.; Tholouli, E.; de Wreede, L.C.; Schönland, S.; Garderet, L.; Drozd-Sokolowska, J.; Raj, K.; McLornan, D.P.; Hayden, P.J.; Yakoub-Agha, I.
Source
In: Bone Marrow Transplantation . (Bone Marrow Transplantation, April 2024, 59(4):526-533)
Subject
Language
English
ISSN
14765365
02683369
02683369